Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

The good news is that, with significant late-stage pipeline activity, new early-stage projects, and continued strong ...

Hummelstown native and three-decade Little League football coach Steve Messick was enjoying Super Bowl LIX in February when ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

The two neurodegenerative diseases could not appear more different. Amyotrophic lateral sclerosis (ALS), sometimes called Lou ...

Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.

I think it's great to see others recognizing the importance of Graves' as a disease. It's great to see more people working on ...

New tools that create ultra-precise maps of our tissues are transforming our ability to diagnose and cure once-fatal ...

Panelists share how they tailor therapy based on patient characteristics, symptoms, and clinical findings.

Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...